Pomotrelvir

N/A

Report date: 2024/12/12 20:00:07
NME

Base Information

Drug NamePomotrelvir
Drug Alias NamePBI-0451
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitorsSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPardes Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesPardes Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A